Potentiation of interleukin 1α mediated antitumor effects by ketoconazole

Paul G Braunschweiger, Nirmal Kumar, Ioannis Constantinidis, Janna P. Wehrle, Jerry D. Glickson, Candace S. Johnson, Philip Furmanski

Research output: Contribution to journalArticle

24 Citations (Scopus)

Abstract

In the present studies, the regulatory role of adrenal hormones on the antitumor activity of recombinant human interleukin 1α (IL-1α) was investigated. Ketoconazole, a potent but transient inhibitor of adrenal steroid hormone biosynthesis, inhibited IL-1α induced increases in plasma corticosterone. In s.c. RIF-1 tumors (C3H/HeJ mice) ketoconazole potentiated IL-1α induced hemorrhagic necrosis (59Fe labeled RBC uptake) and prolonged intervals of low tumor perfusion (86Rb+ uptake) and attendant depletion of tumor high energy phosphate reserves as determined by in vivo 31P nuclear magnetic resonance spectroscopy. In normal muscle and skin the ketoconazole-IL-1α combination had no effect on RBC content and little or no effect on tissue perfusion. Ketoconazole potentiation of IL-1α induced tumor pathophysiologies was accompanied by time and ketoconazole dose dependent potentiation of RIF-1 tumor clonogenic cell killing. Although ketoconazole at 40 mg/kg and IL-1α at 25 μg/kg alone each produced approximately 50% clonogenic cell kill, a combined treatment (IL-1α 1 h after ketoconazole) resulted in surviving fractions of approximately 1.5%. In vitro, ketoconazole and IL-1α induced only additive clonogenic cell kill in primary RIF-1 explant cultures. The effect of elevated plasma corticosterone levels, induced by ketamine-acepromazine anesthesia, on IL-1α responsiveness was also studied in the RIF-1 tumor model. In C3H/HeJ mice, anesthesia increased plasma corticosterone levels within 30 min, abrogated the IL-1α effect on tumor perfusion, and prevented depletion of tumor high energy phosphate metabolite reserves. Our results are consistent with the hypothesis that IL-1α mediated adrenal hormone responses exert a profound negative feedback on IL-1α antitumor activities. Our data also indicate that adrenal steroid hormone biosynthetic pathways could provide a focus for modulation strategies to increase the efficacy of cytokine based therapeutic interventions.

Original languageEnglish
Pages (from-to)4709-4717
Number of pages9
JournalCancer Research
Volume50
Issue number15
StatePublished - Aug 1 1990
Externally publishedYes

Fingerprint

Ketoconazole
Interleukin-1
Neoplasms
Corticosterone
Hormones
Inbred C3H Mouse
Perfusion
Anesthesia
Acepromazine
Steroids
Phosphates
Biosynthetic Pathways
Ketamine
Human Activities
Necrosis
Magnetic Resonance Spectroscopy

ASJC Scopus subject areas

  • Cancer Research
  • Oncology

Cite this

Braunschweiger, P. G., Kumar, N., Constantinidis, I., Wehrle, J. P., Glickson, J. D., Johnson, C. S., & Furmanski, P. (1990). Potentiation of interleukin 1α mediated antitumor effects by ketoconazole. Cancer Research, 50(15), 4709-4717.

Potentiation of interleukin 1α mediated antitumor effects by ketoconazole. / Braunschweiger, Paul G; Kumar, Nirmal; Constantinidis, Ioannis; Wehrle, Janna P.; Glickson, Jerry D.; Johnson, Candace S.; Furmanski, Philip.

In: Cancer Research, Vol. 50, No. 15, 01.08.1990, p. 4709-4717.

Research output: Contribution to journalArticle

Braunschweiger, PG, Kumar, N, Constantinidis, I, Wehrle, JP, Glickson, JD, Johnson, CS & Furmanski, P 1990, 'Potentiation of interleukin 1α mediated antitumor effects by ketoconazole', Cancer Research, vol. 50, no. 15, pp. 4709-4717.
Braunschweiger PG, Kumar N, Constantinidis I, Wehrle JP, Glickson JD, Johnson CS et al. Potentiation of interleukin 1α mediated antitumor effects by ketoconazole. Cancer Research. 1990 Aug 1;50(15):4709-4717.
Braunschweiger, Paul G ; Kumar, Nirmal ; Constantinidis, Ioannis ; Wehrle, Janna P. ; Glickson, Jerry D. ; Johnson, Candace S. ; Furmanski, Philip. / Potentiation of interleukin 1α mediated antitumor effects by ketoconazole. In: Cancer Research. 1990 ; Vol. 50, No. 15. pp. 4709-4717.
@article{e764e7897ead4b16a295be8dee89abf7,
title = "Potentiation of interleukin 1α mediated antitumor effects by ketoconazole",
abstract = "In the present studies, the regulatory role of adrenal hormones on the antitumor activity of recombinant human interleukin 1α (IL-1α) was investigated. Ketoconazole, a potent but transient inhibitor of adrenal steroid hormone biosynthesis, inhibited IL-1α induced increases in plasma corticosterone. In s.c. RIF-1 tumors (C3H/HeJ mice) ketoconazole potentiated IL-1α induced hemorrhagic necrosis (59Fe labeled RBC uptake) and prolonged intervals of low tumor perfusion (86Rb+ uptake) and attendant depletion of tumor high energy phosphate reserves as determined by in vivo 31P nuclear magnetic resonance spectroscopy. In normal muscle and skin the ketoconazole-IL-1α combination had no effect on RBC content and little or no effect on tissue perfusion. Ketoconazole potentiation of IL-1α induced tumor pathophysiologies was accompanied by time and ketoconazole dose dependent potentiation of RIF-1 tumor clonogenic cell killing. Although ketoconazole at 40 mg/kg and IL-1α at 25 μg/kg alone each produced approximately 50{\%} clonogenic cell kill, a combined treatment (IL-1α 1 h after ketoconazole) resulted in surviving fractions of approximately 1.5{\%}. In vitro, ketoconazole and IL-1α induced only additive clonogenic cell kill in primary RIF-1 explant cultures. The effect of elevated plasma corticosterone levels, induced by ketamine-acepromazine anesthesia, on IL-1α responsiveness was also studied in the RIF-1 tumor model. In C3H/HeJ mice, anesthesia increased plasma corticosterone levels within 30 min, abrogated the IL-1α effect on tumor perfusion, and prevented depletion of tumor high energy phosphate metabolite reserves. Our results are consistent with the hypothesis that IL-1α mediated adrenal hormone responses exert a profound negative feedback on IL-1α antitumor activities. Our data also indicate that adrenal steroid hormone biosynthetic pathways could provide a focus for modulation strategies to increase the efficacy of cytokine based therapeutic interventions.",
author = "Braunschweiger, {Paul G} and Nirmal Kumar and Ioannis Constantinidis and Wehrle, {Janna P.} and Glickson, {Jerry D.} and Johnson, {Candace S.} and Philip Furmanski",
year = "1990",
month = "8",
day = "1",
language = "English",
volume = "50",
pages = "4709--4717",
journal = "Journal of Cancer Research",
issn = "0099-7013",
publisher = "American Association for Cancer Research Inc.",
number = "15",

}

TY - JOUR

T1 - Potentiation of interleukin 1α mediated antitumor effects by ketoconazole

AU - Braunschweiger, Paul G

AU - Kumar, Nirmal

AU - Constantinidis, Ioannis

AU - Wehrle, Janna P.

AU - Glickson, Jerry D.

AU - Johnson, Candace S.

AU - Furmanski, Philip

PY - 1990/8/1

Y1 - 1990/8/1

N2 - In the present studies, the regulatory role of adrenal hormones on the antitumor activity of recombinant human interleukin 1α (IL-1α) was investigated. Ketoconazole, a potent but transient inhibitor of adrenal steroid hormone biosynthesis, inhibited IL-1α induced increases in plasma corticosterone. In s.c. RIF-1 tumors (C3H/HeJ mice) ketoconazole potentiated IL-1α induced hemorrhagic necrosis (59Fe labeled RBC uptake) and prolonged intervals of low tumor perfusion (86Rb+ uptake) and attendant depletion of tumor high energy phosphate reserves as determined by in vivo 31P nuclear magnetic resonance spectroscopy. In normal muscle and skin the ketoconazole-IL-1α combination had no effect on RBC content and little or no effect on tissue perfusion. Ketoconazole potentiation of IL-1α induced tumor pathophysiologies was accompanied by time and ketoconazole dose dependent potentiation of RIF-1 tumor clonogenic cell killing. Although ketoconazole at 40 mg/kg and IL-1α at 25 μg/kg alone each produced approximately 50% clonogenic cell kill, a combined treatment (IL-1α 1 h after ketoconazole) resulted in surviving fractions of approximately 1.5%. In vitro, ketoconazole and IL-1α induced only additive clonogenic cell kill in primary RIF-1 explant cultures. The effect of elevated plasma corticosterone levels, induced by ketamine-acepromazine anesthesia, on IL-1α responsiveness was also studied in the RIF-1 tumor model. In C3H/HeJ mice, anesthesia increased plasma corticosterone levels within 30 min, abrogated the IL-1α effect on tumor perfusion, and prevented depletion of tumor high energy phosphate metabolite reserves. Our results are consistent with the hypothesis that IL-1α mediated adrenal hormone responses exert a profound negative feedback on IL-1α antitumor activities. Our data also indicate that adrenal steroid hormone biosynthetic pathways could provide a focus for modulation strategies to increase the efficacy of cytokine based therapeutic interventions.

AB - In the present studies, the regulatory role of adrenal hormones on the antitumor activity of recombinant human interleukin 1α (IL-1α) was investigated. Ketoconazole, a potent but transient inhibitor of adrenal steroid hormone biosynthesis, inhibited IL-1α induced increases in plasma corticosterone. In s.c. RIF-1 tumors (C3H/HeJ mice) ketoconazole potentiated IL-1α induced hemorrhagic necrosis (59Fe labeled RBC uptake) and prolonged intervals of low tumor perfusion (86Rb+ uptake) and attendant depletion of tumor high energy phosphate reserves as determined by in vivo 31P nuclear magnetic resonance spectroscopy. In normal muscle and skin the ketoconazole-IL-1α combination had no effect on RBC content and little or no effect on tissue perfusion. Ketoconazole potentiation of IL-1α induced tumor pathophysiologies was accompanied by time and ketoconazole dose dependent potentiation of RIF-1 tumor clonogenic cell killing. Although ketoconazole at 40 mg/kg and IL-1α at 25 μg/kg alone each produced approximately 50% clonogenic cell kill, a combined treatment (IL-1α 1 h after ketoconazole) resulted in surviving fractions of approximately 1.5%. In vitro, ketoconazole and IL-1α induced only additive clonogenic cell kill in primary RIF-1 explant cultures. The effect of elevated plasma corticosterone levels, induced by ketamine-acepromazine anesthesia, on IL-1α responsiveness was also studied in the RIF-1 tumor model. In C3H/HeJ mice, anesthesia increased plasma corticosterone levels within 30 min, abrogated the IL-1α effect on tumor perfusion, and prevented depletion of tumor high energy phosphate metabolite reserves. Our results are consistent with the hypothesis that IL-1α mediated adrenal hormone responses exert a profound negative feedback on IL-1α antitumor activities. Our data also indicate that adrenal steroid hormone biosynthetic pathways could provide a focus for modulation strategies to increase the efficacy of cytokine based therapeutic interventions.

UR - http://www.scopus.com/inward/record.url?scp=0025297607&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0025297607&partnerID=8YFLogxK

M3 - Article

C2 - 2369744

AN - SCOPUS:0025297607

VL - 50

SP - 4709

EP - 4717

JO - Journal of Cancer Research

JF - Journal of Cancer Research

SN - 0099-7013

IS - 15

ER -